Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-27

Clinical Trial Update: A Study of GLWL-01 in Patients With Prader-Willi Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of GLWL-01 in Prader-Willi Syndrome completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLWL-01

Snippet

Sponsor: GLWL Research Inc. | Conditions: Prader-Willi Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2020-03-27